This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Loh ML, Mullighan CG . Advances in the genetics of high-risk childhood B-progenitor acute lymphoblastic leukemia and juvenile myelomonocytic leukemia: implications for therapy. Clin Cancer Res 2012; 18: 2754–2767.
Den Boer ML, van Slegtenhorst M, De Menezes RX, Cheok MH, Buijs-Gladdines JG, Peters ST et al. A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study. Lancet Oncol 2009; 10: 125–134.
Mullighan CG, Goorha S, Radtke I, Miller CB, Coustan-Smith E, Dalton JD et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 2007; 446: 758–764.
Harvey RC, Mullighan CG, Wang X, Dobbin KK, Davidson GS, Bedrick EJ et al. Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome. Blood 2010; 116: 4874–4884.
Trageser D, Iacobucci I, Nahar R, Duy C, von Levetzow G, Klemm L et al. Pre-B cell receptor-mediated cell cycle arrest in Philadelphia chromosome-positive acute lymphoblastic leukemia requires IKAROS function. J Exp Med 2009; 206: 1739–1753.
van Delft FW, Horsley S, Colman S, Anderson K, Bateman C, Kempski H et al. Clonal origins of relapse in ETV6-RUNX1 acute lymphoblastic leukemia. Blood 2011; 117: 6247–6254.
Hertzberg L, Vendramini E, Ganmore I, Cazzaniga G, Schmitz M, Chalker J et al. Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group. Blood 2010; 115: 1006–1017.
Kuster L, Grausenburger R, Fuka G, Kaindl U, Krapf G, Inthal A et al. ETV6/RUNX1-positive relapses evolve from an ancestral clone and frequently acquire deletions of genes implicated in glucocorticoid signaling. Blood 2011; 117: 2658–2667.
Buitenkamp TD, Pieters R, Gallimore NE, van der Veer A, Meijerink JP, Beverloo HB et al. Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations. Leukemia 2012; 26: 2204–2211.
Zhang J, Mullighan CG, Harvey RC, Wu G, Chen X, Edmonson M et al. Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood 2011; 118: 3080–3087.
Bowman WP, Larsen EL, Devidas M, Linda SB, Blach L, Carroll AJ et al. Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: results of Children's Oncology Group trial P9906. Pediatr Blood Cancer 2011; 57: 569–577.
Mullighan CG, Su X, Zhang J, Radtke I, Phillips LA, Miller CB et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med 2009; 360: 470–480.
Schiffman JD, Lorimer PD, Rodic V, Jahromi MS, Downie JM, Bayerl MG et al. Genome wide copy number analysis of paediatric Burkitt lymphoma using formalin-fixed tissues reveals a subset with gain of chromosome 13q and corresponding miRNA over expression. Br J Haematol 2011; 155: 477–486.
Brauninger A, Goossens T, Rajewsky K, Kuppers R . Regulation of immunoglobulin light chain gene rearrangements during early B cell development in the human. Eur J Immunol 2001; 31: 3631–3637.
Korsmeyer SJ, Hieter PA, Sharrow SO, Goldman CK, Leder P, Waldmann TA . Normal human B cells display ordered light chain gene rearrangements and deletions. J Exp Med 1982; 156: 975–985.
Hogan LE, Meyer JA, Yang J, Wang J, Wong N, Yang W et al. Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies. Blood 2011; 118: 5218–5226.
Mullighan CG, Downing JR . Genome-wide profiling of genetic alterations in acute lymphoblastic leukemia: recent insights and future directions. Leukemia 2009; 23: 1209–1218.
Herzog S, Reth M, Jumaa H . Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling. Nat Rev Immunol 2009; 9: 195–205.
Minegishi Y, Coustan-Smith E, Wang YH, Cooper MD, Campana D, Conley ME . Mutations in the human lambda5/14.1 gene result in B cell deficiency and agammaglobulinemia. J Exp Med 1998; 187: 71–77.
Shimizu T, Mundt C, Licence S, Melchers F, Martensson IL . VpreB1/VpreB2/lambda 5 triple-deficient mice show impaired B cell development but functional allelic exclusion of the IgH locus. J Immunol 2002; 168: 6286–6293.
Acknowledgements
JDS was supported by American Society of Hematology (ASH) Scholar Award, CureSearch Foundation Award, Cancer and Control Population Sciences Pilot Award from Huntsman Cancer Institute, and is the Edward B Clark, MD Chair in Pediatric Research. DSM was supported by Albert Einstein School of Medicine Student Exchange Program. SPH is the Ergen Family Chair in Pediatric Cancer. CGM is Pew Scholar in the Biomedical Sciences and a St Baldrick's Scholar. MM is a Scholar of the Leukemia and Lymphoma Society and a Senior Investigator of the Wellcome Trust. This work was also supported by grants to the COG including the COG Chair’s grant (CA98543) and a supplement to support the TARGET Project, U10 CA98413 (COG Statistical Center) and U24 CA114766 (COG Specimen Banking), and the American Lebanese Syrian Associated Charities of St Jude Children’s Research Hospital.
AUTHOR CONTRIBUTIONS
DSM, JD, CCM, MM, NM, NT, JKF, RCH, SPH, JJY, PB, CGM, RRM, and JDS wrote the paper. DSM, JD, CCM, MSJ, JJY, RRM, and JDS designed and performed research. MM and SPH contributed reagents, cell lines and/or samples. CLW, RCH, SPH, JJY, CGM contributed genomic data.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
JDS is a scientific consultant for Affymetrix, Inc. The remaining authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on the Leukemia website
Supplementary information
Rights and permissions
About this article
Cite this article
Mangum, D., Downie, J., Mason, C. et al. VPREB1 deletions occur independent of lambda light chain rearrangement in childhood acute lymphoblastic leukemia. Leukemia 28, 216–220 (2014). https://doi.org/10.1038/leu.2013.223
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2013.223
This article is cited by
-
An in-depth analysis reveals two new genetic variants on 22q11.2 associated with vitiligo in the Chinese Han population
Molecular Biology Reports (2021)
-
Autoimmunity checkpoints as therapeutic targets in B cell malignancies
Nature Reviews Cancer (2018)
-
The pre-B-cell receptor checkpoint in acute lymphoblastic leukaemia
Leukemia (2015)